Main Article Content

Abstract

Protein is one of the substances of nutrition macro that is needed by the body are known to contain bioactive peptides. Protein sources can be from vegetables and animals, based on research an animal protein sources more complete, balanced, easily digested and absorbed than vegetable protein sources. Some sources of animal protein (milk, eggs, meat, and products derived and processed) were reported that contain of bioactive peptides. Bioactive peptide has effect as antimicrobial, antithrombotic, antihypertensive, opioid, immunomodulatory, binder minerals, antioxidants, and prevent mental health disorder. The purpose of this paper is to review the peptide bioactive, relationship of mental health with peptide bioactive, and prevention of mental helath problems with bioactive peptide from animal protein sources. Peptides bioactive is an organic substance that is formed by amino acids (2-30 pieces) with the bond of the peptide and the weight of the molecule is small (unit Dalton). Mental health is the condition of the welfare (well-being) of an individual that is aware of its ability to own, can cope with the pressure of life which is normal, can work in a productive and can give a contribution to the community. Peptides bioactive shows such as opioids and inhibit the activity of the enzyme prolyl endopeptidase (PEP, EC 3.4.21.26) that play a role important in the treatment of disorders of the mind because work on the system nerve central (CNS) and can give the effect of a positive on motivation, behavior, stress, control the intake of food or the perception of the sense of pain. Some proteins of animal that has been proven to be able to prevent mental health problems namely, bovine, yogurt, and fresh milk. Still a lot of opportunities in the business of exploration of the source of the protein animal in producing the product peptide bioactive for commercial.

Keywords

Animal protein sources bioactive peptides mental health prevention

Article Details

References

  1. Aldrich, J.V., Kulkarni, S.S., Senadheera, S.N., Ross, N.C., Reilley, K.J., Eans, S.O., Ganno, M.L., Murray, T.F., & McLaughlin, J.P. (2011). Unexpected Opioid Activity Profiles of Analogues of The Novel Peptide Kappa Opioid Receptor Ligand CJ-15,208. ChemMedChem, 6, 1739–1745. 10.1002/cmdc.201100113
  2. Angraini, D.I. (2014). Hubungan Depresi dengan Status Gizi. Medula, 2(2), 39-46
  3. Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. (2013). Riset Kesehatan Dasar Riskesdas 2013. Retrived from https://pusdatin.kemkes.go.id/resources/download/general/Hasil%20Riskesdas%202013.pdf.
  4. Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. (2018). Hasil Utama Riskesdas 2018. Retrived from http://www.depkes.go.id/resources/download/info-terkini/hasil-riskesdas-2018.pdf.
  5. Brantl, V., Gramsch, C., Lottspeich, F., Mertz, R., Jaeger, K.H., & Herz, A. (1986). Novel Opioid Peptides Derived from Haemoglobin: Hemorphins. European Journal of Pharmacology, 125(2), 309-310. 10.1016/0014-2999(86)90044-0
  6. Chaudhary, A., Bhalla, S., Patiyal, S., Gajendra, P.S., Raghava, & Sahni, G. (2021). Ferm FooDb: A Database of Bioactive Peptides Derived from Fermented Foods. Heliyon, 7, 1-12. https://doi.org/10.1016/j.heliyon.2021.e06668
  7. Collinder, E., Nyberg, F., Sanderson-Nydahl, K., Gottlieb-Vedi, M., & Lindholm, A. (2005). The Opioid Haemorphin-7 In Horses During Low-Speed and High-Speed Treadmill Exercise to Fatigue. Journal of Veterinary Medicine Series, 52, 162–165. 10.1111/j.1439-0442.2005.00712.x
  8. Górska-Warsewicz, H., Laskowski, W., Kulykovets, O., Kudli?ska-Chylak, A., Czeczotko, M., & Rejman, K. (2018). Food Products as Sources of Protein and Amino Acids—The Case of Poland. Nutrients, 10, 1977. 10.3390/nu10121977
  9. Hayes, M., Moen, L.F., Auty, M.A., & Lea, T.E. (2015). Transport of a Prolyl Endopeptidase Inhibitory Peptide Across The Blood-Brain Barrier Demonstrated Using The Hcmec/D3 Cell Line Transcytosis Assay. Journal of Agricultural and Food Chemistry, 64(1), 146–150. 10.1021/acs.jafc.5b04696
  10. Hayes, M., Ross, R.P., Fitzgerald, G.F., & Stanton, C. (2007). Putting Microbes to Work: Dairy Fermentation, Cell Factories, and Bioactive Peptides. Part I: Overview. Biotechnology Journal, 2, 426–434. 10.1002/biot.200600246
  11. Jäkälä, P., & Vapaatalo, H. (2010). Antihypertensive Peptides from Milk Proteins. Pharmaceuticals, 3, 251–272. 10.3390/ph3010251
  12. Khoirunissa, D.H. & Sukartini, N.M. (2020). Kesehatan Mental Sumber Daya Manusia Indonesia. Jurnal Sains Sosio Huaniora, 4(1), 241-258. https://doi.org/10.22437/jssh.v4i1.9919
  13. Kitts, D.D. & Weiler, K. (2003). Bioactive Proteins and Peptides from Food Sources. Applications df Bioprocesses Used in Isolation and Recovery. Current Pharmaceutical Design, 9, 1309–132. 10.2174/1381612033454883
  14. Lafarga, T., O’Connor, P., & Hayes, M. (2015). In Silico Methods to Identify Meat-Derived Prolyl Endopeptidase Inhibitors. Food Chemistry, 175, 337-343. https://doi.org/10.1016/j.foodchem.2014.11.150
  15. Lafarga, T. & Hayes, M. (2014). Bioactive Peptides from Meat Muscle and By-Products: Generation, Functionality, and Application as Functional Ingredients. Meat Science, 98, 227–239. https://doi.org/10.1016/j.meatsci.2014.05.036
  16. Mariotti, F. & Gardner, C.D. (2019). Dietary Protein and Amino Acids in Vegetarian Diets—A Review. Nutrients, 11, 2661. 10.3390/nu11112661
  17. Martinez-Alvarez, O. (2013). Hormone-like Peptides Obtained by Marine-protein Hydrolysis and Their Bioactivities. In K. Se-Know (Ed.), Marine Proteins and Peptides (pp 351- 368). Ames, Iowa: Wiley-Blackwell
  18. Momeni, N., Nordström, B., Horstmann, V., Avarseji, H., & Sivberg, B. (2005). Alterations of Prolyl Endopeptidase Activity in The Plasma of Children with Autistic Spectrum Disorders. BMC Psychiatry, 5(1), 1-6. 10.1186/1471-244X-5-27
  19. Morain, P., Lestage, P., De Nanteuil, G., Jochemsen, R., Robin, J.L., Guez, D., & Boyer, P.A. (2002). S 17092: A Prolyl Endopeptidase Inhibitor as a Potential Therapeutic Drug for Memory Impairment: Preclinical and Clinical Studies. CNS Drug Reviews, 8(1), 31-52. 10.1111/j.1527-3458.2002.tb00214.x
  20. Ohinata, K., Sonoda, S., Inoue, N., Yamauchi, R., Wada, K., & Yoshikawa, M. (2007). ?-Lactotensin, a Neurotensin Agonist Peptide Derived from Bovine ?-Lactoglobulin, Enhances Memory Consolidation in Mice. Peptides, 28(7), 1470-1474. 10.1016/j.peptides.2007.06.002
  21. Ohmori, T., Nakagami, T., Tanaka, H., & Maruyama, S. (1994). Isolation of Prolylendopeptidase-Inhibiting Peptides from Bovine Brain. Biochemical and Biophysical Research Communications, 202(2), 809-815. 10.1006/bbrc.1994.2002
  22. Piot, J.M., Zhao, Q., Guillochon, D., Ricart, G., & Thomas, D. (1992). Isolation and Characterization of 2 Opioid-Peptides from a Bovine Hemoglobin Peptic Hydrolysate. Biochemical and Biophysical Research Communications, 189(1), 101- 110. https://doi.org/10.1016/0006-291X(92)91531-T
  23. Ridlo, I. A. 2017. Indonesia Darurat Kesehatan Mental? Retrieved from https://www.researchgate.net/publication/315754402
  24. Sánchez, A. & Vázquez, A. (2017). Bioactive Peptides: A Review. Food Quality and Safety, 1, 29–46. https://doi.org/10.1093/fqsafe/fyx006
  25. Tyagi, A., Banan-Mwine Daliri, E., Ofosu, F.K., Su-Jung Yeon, & Deog-Hwan Oh. (2020). Food-Derived Opioid Peptides in Human Health: A Review. International Journal of Molecular Science, 21, 8825. https://doi.org/10.3390/ijms21228825
  26. Wang, S., Waterhouse, D.S., Waterhouse, G.I.N., Zheng, L., Su, G., & Zhao, M. (2021). Effects of Food-Derived Bioactive Peptides on Cognitive Deficits and Memory Decline in Neurodegenerative Diseases: A review. Trends in Food Science & Technology, 116, 712–732. https://doi.org/10.1016/j.tifs.2021.04.056
  27. Wang, X., Yu, H., Xing, R., Liu, S., Chen, X., & Li, P. (2018). Effect and Mechanism of Oyster Hydrolytic Peptides on Spatial Learning and Memory in Mice. RSC Advances, 8(11), 6125-6135
  28. WHO. (2017). Factsheet on Mental Disorders. Geneva: World Health Organization. Retrieved from http://www.who.int/mediacentre/factshee ts/fs396/en/
  29. WHO. 2013. Mental Health Action Plan 2013 – 2020. Geneva: World Health Organization. Retrieved from https://www.who.int/publications/i/item/9789240031029